Therefore, blocking inhibitory signaling by PD-1/PD-L1 with antibodies can suppress tumor growth by directly inhibiting tumor cell proliferation or reactivating cytotoxic T-cell behavior [6,9,10]. Here, PDCD1 is linked to neoplasm.